- China Tower reported a net income of 10.73 billion yuan for the fiscal year, falling short of the estimated 10.97 billion yuan.
- The company’s operating revenue slightly exceeded expectations, reaching 97.77 billion yuan compared to the estimated 97.69 billion yuan.
- Revenue from the tower business segment was 75.69 billion yuan, narrowly missing the estimate of 75.82 billion yuan.
- Capital expenditure for the year amounted to 31.94 billion yuan.
- A final dividend of 30.796 RMB cents per share was declared.
- Currently, there are 11 buy ratings, 4 hold ratings, and no sell ratings for China Tower stock.
A look at China Tower Smart Scores
Factor | Score | Magnitude |
---|---|---|
Value | 5 | |
Dividend | 5 | |
Growth | 4 | |
Resilience | 3 | |
Momentum | 5 | |
OVERALL SMART SCORE | 4.4 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
China Tower Corporation Limited, a leading telecommunications company in China, appears to have a positive long-term outlook based on its Smartkarma Smart Scores. With top scores in Value and Dividend, as well as strong Momentum, the company seems well-positioned for growth and stability. While its Growth score is slightly lower, China Tower’s Resilience score indicates a moderate level of robustness to market challenges. Overall, the company’s smart scores imply a promising future in the telecommunications sector.
China Tower Corporation Limited is a telecommunication company that specializes in tower construction, maintenance, and facilities management across China. With impressive scores across key factors such as Value, Dividend, and Momentum, the company showcases a strong foundation for potential growth. Although its Resilience score is not the highest, China Tower’s overall smart scores paint a favorable picture of its future prospects in the industry.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars